/
/
/
Professor Nikola Bowden

Professor Nikola Bowden

Research Fellow, University of Newcastle

Australian Program for Drug Repurposing for Treatment Resistant Ovarian Cancer funded by Medical Research Future Fund ($2.69m 2020-2025)
PRIME005: Phase Ib/II study of Azacitidine and Carboplatin priming before Ipilimumab and Nivolumab re-challenge in advanced melanoma patients resistant to immunotherapy, supported by Bristol Myers Squibb
Chief Investigator of the NSW Regional Cancer Research Network, $5.6m funded by the Cancer Institute NSW Translational Cancer Research Capacity Building Grant Program

Professor Nikola Bowden is the Vanessa McGuigan HMRI Fellow in Ovarian Cancer Research and Chief Investigator of the NSW Regional Cancer Research Network, a Cancer Institute NSW Translational Cancer Research Capacity Building Grant.
 
Professor Bowden’s research investigates DNA repair, immunotherapy and drug repurposing for melanoma and ovarian cancer.

She leads the MRFF-funded Australian Program for Drug Repurposing for Treatment Resistant Ovarian Cancer and several Investigator-initiated clinical trials for treatment-resistant cancers in collaboration with the Pharmaceutical Industry.

Professor Bowden has previously held Chair of the Australian Academy of Science Early and Mid-Career Researcher Forum, as well as funding from Cancer Australia, Cure Cancer Australia, Cancer Institute NSW Career Development Fellowship, and a NHMRC Training Fellowship.